 | Chemomab Therapeutics Ltd. | |||
| NCM : CMMB || Location: Israel | ||||
$0.67+0.01 (+1.52%) |
0.01 M | 0.65 - 0.68 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.222 M |
| March 15, 2024 | 0.194 M |
| Feb. 29, 2024 | 0.244 M |
| Feb. 15, 2024 | 0.038 M |
| Jan. 31, 2024 | 0.033 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.02 | -0.02 | 16.67% |
| 03/31/2023 | -0.03 | -0.80 | -2514.38% |
| 12/31/2022 | -0.04 | -0.73 | -1689.22% |
| 09/30/2022 | -0.34 | -0.04 | 89.60% |
| 06/30/2022 | -0.25 | -0.54 | -116.00% |
CMMB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 14.205M | Shares Float | 14.205M |
| Short Float | 0.222M | Market Cap | 9.38M |
| Institution ownership | 24.96% | Insider ownership | 14.988% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.06 | Forward EPS | -0.09 |